Form 13-F position report

ASCENDIS PHARMA A/S

Reported by PERCEPTIVE ADVISORS LLC

ASND CUSIP K08588103 Manager CIK 0001224962

Reported 971,521 shares, down 192,200 (16.5%) from the prior quarter.

Reported value -28.7%; share count -16.5% vs. the prior quarter.

Reduced
% of reported 13F value 3.86% This manager · Q3 2026
Shares 971,521 Quarter-end amount reported
Reported value $221,341,629 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-06-30 310387665
2026-09-30 221341629

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for ASCENDIS PHARMA A/S held by PERCEPTIVE ADVISORS LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 971,521 -192,200 (-16.5%) 3.86% $221,341,629 2026-11-16
Q2 2026 New 1,163,721 +1,163,721 (0.0%) 4.66% $310,387,665 2026-08-14

Who else reported the position

381 managers reported ASCENDIS PHARMA A/S for Q3 2026.

Managers reporting ASCENDIS PHARMA A/S in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
RA CAPITAL MANAGEMENT L P Unchanged 10,281,496 0 23.5% $2,342,433,234 2 qtrs
T Rowe Price Investment Management Inc Added 8,187,877 +1,433,031 1.31% $1,865,445,000 3 qtrs
WESTFIELD CAPITAL MANAGEMENT CO LP Added 5,125,027 +326,760 3.82% $1,167,634,813 2 qtrs
Avoro Capital Advisors LLC Reduced 5,050,000 -61,111 11.87% $1,150,541,500 2 qtrs
JANUS HENDERSON GROUP PLC New 3,636,032 +3,636,032 0.35% $828,493,126 1 qtr
FMR LLC Reduced 3,445,493 -100,082 0.03% $784,986,781 2 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 3,070,399 +1,521,763 0.12% $699,529,004 2 qtrs
BlackRock Inc Added 2,284,011 +72,178 < 0.01% $520,366,227 2 qtrs
Artisan Partners Limited Partnership Reduced 2,083,019 -551,005 0.87% $474,581,269 2 qtrs
MASSACHUSETTS FINANCIAL SERVICES CO MA Added 1,896,095 +20,794 0.15% $431,925,066 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
ORD SHS

Voting authority reported

Sole
971,521
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.